2009 | 2010 | 2011 |
2012 |
2013 | 2014 | |
Corporate capital | 9.000.000 | 9.000.000 | 9.000.000 | 9.000.000 | 9.000.000 | 9.00.000 |
---|---|---|---|---|---|---|
Reserves | 18.120.768 | 18.120.768 | 18.120.768 | 18.120.768 | 18.120.768 | 18.120.768 |
Profit brought forward | 4.238.597 | 3.339.629 | 2.810.890 | 2.239.410 | 1.747.845 | 372.809 |
Other equity | 3.207.205 | 3.175.947 | 3.067.890 | 2.040.267 | 2.097.036 | 1.985.225 |
Profit for the year | 599.067 | -168.739 | -1.540.190 | -491.565 | -1.375.036 | -7.414.314 |
Total | 35.165.637 | 33.467.605 | 31.459.358 | 30.908.880 | 29.590.613 | 22.064.487 |
2009 | 2010 | 2011 | 2012 | 2013 | 2014 |
---|---|---|---|---|---|
540.000 | 360.000 | 0 | 0 | 0 | 0 |
2009 | 2010 | 2011 |
2012 |
2013 | 2014 | |
Net result | 599.067 | -168.739 | -1.540.190 | -491.565 | -1.375.036 | -7.414.314 |
---|---|---|---|---|---|---|
Investment | 4.536.595 | 2.709.205 | 1.661.198 | 651.501 | 3.267.352 | 2 645 933 |
Equity | 35.165.637 | 33.467.605 | 31.459.358 | 30.908.880 | 29.590.613 | 22.064.487 |
CARDIOLOGIE AND ANGIOLOGIE | ||